Brunton Status Sheet

7/27/2019 Brunton Status Sheet

1/30

Unit + Ch. # Chapter TitleCE

Rec?Folio EPR Indesign

FM

SECTION I: General PrinciplesCH-1 Drug Invention and the Pharmaceutical Industry YES 001-011 Done JyotirCH-2 YES 012-027 Done RamCH-3 YES 028-050 Done AnandCH-4 Drug Toxicity and Poisoning YES 051-064 Done KiranCH-5 Membrane Transporters and Drug Response YES 065-087 Done KiranCH-6 YES 088-104 Done ManojCH-7 YES 105-118 Done Manoj

SECTION II: Neuropharmacology

CH-8

Neurotransmission: The Autonomic and Somatic Motor Nervous

SystemsYES 119-148 Done Virendr

CH-9 YES 149-159 Done DharmendCH-10 Anticholinesterase Agents YES 160-169 Received Anand

CH-11Agents Acting at the Neuromuscular Junction and AutonomicGanglia

YES 170-183 ReceivedDharmend

CH-12 Adrenergic Agonists and Antagonists YES 184-212 DoneJyotir//Din

CH 13 5 H d t t i (S t i ) d D i YES 213 231 DDharmend

Brunton Status


2/30

CH 13 5 Hydroxytryptamine (Serotonin) and Dopamine YES 213 231 Done

CH-50Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis,Trichomoniasis, Trypanosomiasis, Leishmaniasis, and OtherProtozoal Infections

YES 903-915 Received Sa

CH-51 Chemotherapy of Helminth Infections YES 916-927 Received Manoj

CH-52Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones, andA ents for Urinar Tract Infections

YES 928-938 Received M

CH-53 Penicillins, Cephalosporins, and Other -Lactam Antibiotics YES 939-958 Received SatishCH-54 Aminoglycosides YES 959-968 Sent Mano

CH-55 Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents YES 969-988 Received Kiran

CH-56 Chemotherapy of Tuberculosis, Mycobacterium Avium ComplexDisease and Le ros YES 0989-1004 Received Ki

CH-57 Antifungal Agents YES 1005-1020 Received ManojCH-58 Antiviral Agents (Nonretroviral) YES 1021-1039 Received Kiran

CH-59 Antiretroviral Agents and Treatment of HIV Infection YES 1040-1062 Received Gopal

SECTIONVIII:

Chemotherapy of Neoplastic Diseases

CH-60 General Principles of Cancer Chemotherapy YES 1063-1070 Received KiranCH-61 Cytotoxic Agents YES 1071-1111 Received Kiran

CH-62 Targeted Therapies: Tyrosine Kinase Inhibitors, MonoclonalAntibodies, and Cytokines YES 1112-1129 Received Go

CH-63Natural Products in Cancer Chemotherapy: Hormones and RelatedAgents

YES 1130-1140 Received Sat

SECTION IX: Special Systems PharmacologyCH-64 Ocular Pharmacology YES 1141-1164 Received Gopal

CH-65 Dermatological Pharmacology YES 1165-1187 Received Manoj

CH-66Contraception and Pharmacotherapy of Obstetrical and

G necolo ical DisordersYES 1188-1200 Received Sat


3/30


4/30


5/30


6/30


7/30


8/30


9/30


10/30


11/30


12/30


13/30


14/30


15/30


16/30

Unit + Ch. # Chapter TitleEdito

rCrx?

Folio Indesign PQC

FM

SECTION I: General PrinciplesCH-1 Drug Invention and the Pharmaceutical Industry Yes 0001-0011 Satish Sunil K

CH-2Pharmacokinetics: The Dynamics of Drug Absorption,Distribution Metabolism and Elimination

Yes 0012-0026 Satish Anand

CH-3 Pharmacodynamics: Molecular Mechanisms of Drug Action Yes 0027-0049 Kiran KK

CH-4 Drug Toxicity and Poisoning Yes 0050-0062 Satish AnandCH-5 Membrane Transporters and Drug Response Yes 0063-0080 Kiran KKCH-6 Drug Metabolism Yes 0081-0097 Satish Sunil

CH-7 Pharmacogenetics Yes 0098-0110 Satish KK

SECTION II: NeuropharmacologyCH-8 Neurotransmission: The Autonomic and Somatic Motor

Nervous SystemsYes 0111-0137 Virendra Sunil

CH-9 Muscarinic Receptor Agonists and Antagonists Yes 0138-0147 Kiran KKCH-10 Anticholinesterase Agents Yes 0148-0157 Satish Anand

CH-11 Agents Acting at the Neuromuscular Junction and AutonomicGanglia

Yes 0158-0170 Satish Rajkuma

CH-12 Adrenergic Agonists and Antagonists Yes 0171-0199 Gufran Rajkumar

Brunton Status Sh


17/30

CH-46 Gastrointestinal Motility and Water Flux; Emesis; Biliary andPancreatic Disease Yes Virendra

CH-47 Pharmacotherapy of Inflammatory Bowel Disease Yes Satish Paused

SECTION VII: Chemotherapy of Microbial Diseases

CH-48 General Principles of Antimicrobial Therapy Yes Gopal PausedCH-49 Chemotherapy of Malaria Yes Kiran Paused

CH-50Chemotherapy of Protozoal Infections: Amebiasis,Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis,

and Other Protozoal Infections

Yes Gopal

CH-51 Chemotherapy of Helminth Infections Yes Kiran Paused

CH-52Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones,and A ents for Urinar Tract Infections

Yes Kiran

CH-53 Penicillins, Cephalosporins, and Other -Lactam Antibiotics Yes Satish Pause

CH-54 Aminoglycosides Yes Kiran Pau

CH-55Protein Synthesis Inhibitors and Miscellaneous AntibacterialAgents

Yes Satish

CH-56Chemotherapy of Tuberculosis, Mycobacterium AviumComplex Disease, and Leprosy

Yes Kiran

CH-57 Antifungal Agents Yes Anand PausCH-58 Antiviral Agents (Nonretroviral) Yes Virendra Paused

CH-59 Antiretroviral Agents and Treatment of HIV Infection Yes Satish Paused

SECTIONVIII:

Chemotherapy of Neoplastic Diseases

CH-60 General Principles of Cancer Chemotherapy Yes Dinesh (Pause) PausedCH-61 Cytotoxic Agents Yes Dinesh (Pause) Paused

CH-62Targeted Therapies: Tyrosine Kinase Inhibitors, MonoclonalAntibodies and C tokines

Yes Dinesh


18/30


19/30


20/30


21/30


22/30


23/30


24/30


25/30


26/30


27/30


28/30


29/30


30/30

Brunton Status Sheet

Documents

Transcript of Brunton Status Sheet